Nucleophosmin/anaplastic lymphoma kinase (NPM/ALK) oncoprotein induces the T regulatory cell phenotype by activating STAT3

Proceedings of the National Academy of Sciences of the United States of America

Volumn 103, Issue 26, 2006, Pages 9964-9969

  Kasprzycka, Monika ^a,b   Marzec, Michal ^a   Liu, Xiaobin ^a   Zhang, Qian ^a   Wasik, Mariusz A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cell signaling; Immune response evasion; Oncogenesis

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; CD28 ANTIGEN; CD3 ANTIGEN; CHIMERIC PROTEIN; INTERLEUKIN 10; NUCLEOPHOSMIN; ONCOPROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CARCINOGENESIS; CELL LINE; CELL PROLIFERATION; CELL STIMULATION; CELL STRAIN BAF3; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG TARGETING; ENZYME INHIBITION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; TUMOR ESCAPE;

ANTIGENS, CD28; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNOSUPPRESSION; INTERLEUKIN-10; LYMPHOMA, T-CELL; ONCOGENE PROTEINS, FUSION; PROTEIN-TYROSINE KINASES; RECEPTORS, IGE; STAT3 TRANSCRIPTION FACTOR; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 33745587303     PISSN: 00278424     EISSN: None     Source Type: Journal    
DOI: 10.1073/pnas.0603507103     Document Type: Article

References (45)

1. Wasik, M. A. (2002) Am. J. Clin. Pathol. 118, S81-S92.
2. Shiota, M., Fujimoto, J., Semba, T., Satoh, H., Yamamoto, T. & Mori, S. (1994) Oncogene 9, 1567-1574.
3. Morris, S. W., Naeve, C., Mathew, P., James, P. L., Kirstein, M. N., Cui, X. & Witte, D. P. (1997) Oncogene 14, 2175-2188.
4. Fujimoto, J., Shiota, M., Iwahara, T., Seki, N., Satoh, H., Mori, S. & Yamamoto, T. (1996) Proc. Natl. Acad. Sci. USA. 93, 4181-4186.
5. Bischof, D., Pulford, K., Mason, D. Y. & Morris, S. W. (1997) Mol. Cell. Biol. 17, 2312-2325.
6. Kuefer, M. U., Look, A. T., Pulford, K., Behm, F. G., Pattengale, P. K., Mason, D. Y. & Morris, S. W. (1997) Blood 90, 2901-2910.
7. Chiarle, R., Gong, J. Z., Guasparri, I., Pesci, A., Cai, J., Liu, J., Simmons, W. J., Dhall, G., Howes, J., Piva, R., et al. (2003) Blood 101, 1919-1927.
8. Zhang, Q., Raghunath, P. N., Xue, L., Majewski, M., Carpentieri, D. F., Odum, N., Morris, S., Skorski, T. & Wasik, M. A. (2002) J. Immunol. 168, 466-474.
9. Bacchiocchi, R., Baldanzi, G., Carbonari, D., Capomagi, C., Colombo, E., van Blitterswijk, W. J., Graziani, A. & Fazioli, F. (2005) Blood 15, 2175-2182.
10. Marzec, M., Kasprzycka, M., Ptasznik, A., Wlodarski, P., Zhang, Q., Odum, N. & Wasik, M. A. (2005) Lab. Invest. 85, 1544-1554.
11. Pestka, S., Krause, C. D., Sarkar, D., Walter, M. R., Shi, Y. & Fisher, P. B. (2004) Annu. Rev. Immunol. 22, 929-979.
12. Wakkach, A., Fournier, N., Brun, V., Breittmayer, J. P., Cottrez, F. & Groux, H. (2003) Immunity 18, 605-617.
13. Taga, K., Mostowski, H. & Tosato, G. (1993) Blood 81, 2964-2971.
14. Gamero, A. M., Young, H. A. & Wiltrout, R. H. (2004) Cancer Cell. 5, 111-112.
15. O'Garra, A. & Vieira, P. (2004) Nat. Med. 10, 801-805.
16. Chattopadhyay, S., Chakraborty, N. G. & Mukherji, B. (2005) Cancer Immunol. Immunother. 54, 1153-1161.
17. Vieira, P. L., Christensen, J. R., Minaee, S., O'Neill, E. J., Barrat, F. J., Boonstra, A., Barthlott, T., Stockinger, B., Wraith, D. C. & O'Garra, A. (2004) J. Immunol. 172, 5986-5993.
18. Randolph, D. A. & Fathman, C. G. (2006) Annu. Rev. Med. 57, 381-402.
19. Chen, W., Jin, W., Hardegen, N., Lei, K. J., Li, L., Marines, N., McGrady, G. & Wahl, S. M. (2003) J. Exp. Med. 198, 1875-1886.
20. Walker, M. R., Kasprowicz, D. J., Gersuk, V. H., Benard, A., Van Landeghen, M., Buckner, J. H. & Ziegler, S. F. (2003) J. Clin. Invest. 112, 1437-1443.
21. Somasundaram, R., Jacob, L., Swoboda, R., Caputo, L., Song, H., Basak, S., Monos, D., Peritt, D., Marincola, F., Cai, D., et al. (2002) Cancer Res. 62, 5267-5272.
22. Javia, L. R. & Rosenberg, S. A. (2003) J. Immunother. 26, 85-93.
23. Curiel, T. J., Coukos, G., Zou, L., Alvarez, X., Cheng, P., Mottram, P., Evdemon-Hogan, M., Conejo-Garcia, J. R., Zhang, L., Burow, M., et al. (2004) Nat. Med. 10, 942-949.
24. Marshall, N. A., Christie, L. E., Munro, L. R., Culligan, D. J., Johnston, P. W., Barker, R. N. & Vickers, M. A. (2004) Blood 103, 1755-1762.
25. Viguier, M., Lemaitre, F., Verola, O., Cho, M. S., Gorochov, G., Dubertret, L., Bachelcz, H., Kourilsky, P. & Ferradini, L. (2004) J. Immunol. 173, 1444-1453.
26. Matsubara, Y., Hori, T., Morita, R., Sakaguchi, S. & Uchiyama, T. (2005) Leukemia 19, 482-483.
27. Kohno, T., Yamada, Y., Akamatsu, N., Kamihira, S., Imaizumi, Y., Tomonaga, M. & Matsuyama, T. (2005) Cancer Sci. 96, 527-533.
28. Berger, C. L., Tigelaar, R., Cohen, J., Mariwalla, K., Trinh, J., Wang, N. & Edelson, R. L. (2005) Blood 105, 1640-1647.
29. Cohen, S. B., Crawley, J. B., Kahan, M. C., Feldmann, M. & Foxwell, B. M. (1997) Immunology 92, 1-5.
30. Crockett, D., Lin, K. Z., Elenitoba-Johnson, K. S. & Lim, M. S. (2004) Oncogene 23, 2617-2629.
31. Benkhart, E. M., Siedlar, M., Wedel, A., Werner, T. & Ziegler-Heitbrock, H. W. (2000) J. Immunol. 165, 1612-1617.
32. Ziegler-Heitbrock, L., Lotzerich, M., Schaefer, A., Werner, T., Frankenberger, M. & Benkhart, E. (2003) J. Immunol. 171, 285-290.
33. Karube, K., Ohshima, K., Tsuchiya, T., Yamaguchi, T., Kawano, R., Suzumiya, J., Utsunomiya, A., Harada, M. & Kikuchi, M. (2004) Br. J. Haematol. 126, 81-84.
34. Walsh, P. T., Benoit, B. M., Wysocka, M., Dalton, N. M., Turka, L. A. & Rook, A. H. (2006) J. Invest. Dermatol. 126, 690-692.
35. Yu, H. & Jove, R. (2004) Nat. Rev. Cancer 4, 97-105.
36. Wan, W., Albom, M. S., Lu, L., Quail, M. R., Becknell, N. C., Weinberg, L. R., Reddy, D. R., Holskin, B. P., Angeles, T. S., Underiner, T. L., et al. (2006) Blood 107, 1617-1623.
37. Pulford, K., Falini, B., Banham, A. H., Codrington, D., Roberton, H., Hatton, C. & Mason, D. Y. (2000) Blood 96, 1605-1607.
38. Passoni, L., Scardino, A., Bertazzoli, C., Gallo, B., Coluccia, A. M., Lemonnier, F. A., Kosmatopoulos, K. & Gambacorti-Passcrini, C. (2002) Blood 99, 2100-2106.
39. Chan, K. S., Sano, S., Kiguchi, K., Anders, J., Komazawa, N., Takeda, J. & DiGiovanni, J. (2004) J. Clin. Invest. 114, 720-728.
40. Ling, X. & Arlinghaus, R. B. (2005) Cancer Res. 65, 2532-2536.
41. Chiarle, R., Simmons, W. J., Cai, H., Dhall, G., Zamo, A., Raz, R., Karras, J. G., Levy, D. E. & Inghirami, G. (2005) Nat. Med. 11, 623-629.
42. Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., Gabrilovich, D., Heller, R., Coppola, D., et al. (2004) Nat. Med. 10, 48-54.
43. Cheng, F., Wang, H. W., Cuenca, A., Huang, M., Ghansah, T., Brayer, J., Kerr, W. G., Takeda, K., Akira, S., Schoenberger, S. P., et al. (2003) Immunity 19, 425-436.
44. Buettner, R., Mora, L. B. & Jove, R. (2002) Clin. Cancer Res. 8, 945-954.
45. Turkson, J., Kim, J. S., Zhang, S., Yuan, J., Huang, M., Glenn, M., Haura, E., Sebti, S., Hamilton, A. D. & Jove, R. (2004) Mol. Cancer Ther. 3, 261-269.